GCTK stock news · Glucotrack, Inc.
Get alerts for GCTK
Follow Glucotrack, Inc. (GCTK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GCTKGlucotrack, Inc. has been told it will be removed from Nasdaq because its stock price is too low.
Bad for GCTKGlucotrack will lose its Nasdaq listing after missing a required share-price condition. Its planned move to OTC trading may keep shares available, but the change is a serious setback.
Glucotrack, Inc. signs an important deal with warrant holders.
NeutralGlucotrack lifted a limit on issuing shares, but must give holders warrants for 406,198 shares. No funding was reported, so the filing does not clearly change its outlook.
Here are 12 health care stocks that changed a lot during Friday's trading.
NeutralGlucoTrack shares fell 28.69% during Friday's session, but the article gives no company news or reason for the drop. It does not change the outlook for GlucoTrack.
Glucotrack, Inc. signs a big deal to sell shares and raise about $3.1 million.
Bad for GCTKGlucotrack sold shares and pre-funded warrants raising about $3.1M. I read this as bearish because immediate exercise and discounted sale will dilute existing holders.
On Thursday, 12 health care stocks changed a lot during the day.
NeutralGlucoTrack's stock climbed to $2.58 in the session; without any company detail, this price move alone does not change the company's view.
Glucotrack's stock shot up more than 80% after hours because of a new partnership announcement.
NeutralGlucotrack's Lokahi deal validates its AI search but is small and non-binding, so this announcement does not change how we view the company's prospects.
12 health care stocks changed a lot in Wednesday's after-hours trading.
NeutralGlucoTrack's shares jumped after hours, but the article gives no company news, so this does not change how we read the company.
Glucotrack, Inc. shares an update with investors about recent news.
NeutralGlucotrack filed an 8-K furnishing a shareholder update; the filing shows no new business or financial facts, so it is neutral for GCTK.
Glucotrack, Inc. discloses a significant definitive agreement (GCTK).
Bad for GCTKGlucotrack, Inc. has filed a Form 8-K detailing a material definitive agreement, which suggests potential growth or strategic changes that could positively influence its market position and financial health.